Dima Kabbani

Assistant Professor

University of Alberta

Canada

Research Interests

Explore related searches

Professors in Canada Professors in Immunology Immunology professors in Canada

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dima Kabbani is an Assistant Professor at the University of Alberta, Canada. His research focuses on infectious diseases in transplant recipients, evidenced by his recent publications on topics such as measles outbreaks, Mycobacterium abscessus complex infections, and the impacts of cytomegalovirus in solid organ transplant patients. Dr. Kabbani also contributes to antimicrobial stewardship in the context of COVID-19, reflecting his commitment to advancing healthcare outcomes in vulnerable populations.

Articles (16)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

CANADA

View details

Seyed M Hosseini-Moghaddam

university health network and university of toronto

CANADA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Dima Kabbani

Research Interests

Explore related searches

Contact this professor

About

Articles (16)

Measles Outbreaks and Implications for Patients Receiving Stem Cell or Cellular Therapies in Canada: Cell Therapy Transplant Canada (CTTC) Infectious Diseases Working Committee

Mycobacterium abscessus Complex Infections Among Lung Transplant Recipients: A Multicenter Retrospective Cohort Study in Canada

Donor-derived bartonellosis in solid organ transplant recipients from unhoused donors in Alberta

Cytomegalovirus surveillance after antiviral prophylaxis in CMV mismatched transplant patients: Does recurrent cytomegalovirus DNAemia impact patient survival?

Incidence of valganciclovir‐related leukopenia and neutropenia in solid organ transplant recipients at high risk of cytomegalovirus disease

Efficacy and safety of antimicrobial stewardship prospective audit and feedback in patients hospitalised with COVID-19 (COVASP): a pragmatic, cluster-randomised, non-inferiority trial

Omicron BA.4/5 Neutralization and T-Cell Responses in Organ Transplant Recipients After Booster Messenger RNA Vaccine: A Multicenter Cohort Study

Omicron BA.4/5 Neutralization and T-Cell Responses in Organ Transplant Recipients After Booster Messenger RNA Vaccine: A Multicenter Cohort Study

Efficacy and safety of antimicrobial stewardship prospective audit and feedback in patients hospitalised with COVID-19 (COVASP): a pragmatic, cluster-randomised, non-inferiority trial

Immunogenicity, Safety, and Breakthrough Severe Acute Respiratory Syndrome Coronavirus 2 Infections After Coronavirus Disease 2019 Vaccination in Organ Transplant Recipients: A Prospective Multicenter Canadian Study

Immunogenicity, Safety, and Breakthrough Severe Acute Respiratory Syndrome Coronavirus 2 Infections After Coronavirus Disease 2019 Vaccination in Organ Transplant Recipients: A Prospective Multicenter Canadian Study

Immune-Based Therapy for Hospitalized Patients With COVID-19 and Risk of Secondary Infections: A Systematic Review and Meta-analysis

Immune-Based Therapy for Hospitalized Patients With COVID-19 and Risk of Secondary Infections: A Systematic Review and Meta-analysis

Systemic corticosteroids for outpatient respiratory viral infections in lung transplant recipients

Association between gut colonization of vancomycin‐resistant enterococci and liver transplant outcomes

Association between gut colonization of vancomycin-resistant enterococci and liver transplant outcomes

Collaborators (7)

Juan Gonzalez-Abraldes

Uday Deotare

Oscar Alejandro Fernandez Garcia

Carlos Cervera

Karen Doucette

Coleman Rotstein

Seyed M Hosseini-Moghaddam

Make your next move.